These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 10491723

  • 1. Review article: the pharmacology of rabeprazole.
    Williams MP, Pounder RE.
    Aliment Pharmacol Ther; 1999 Aug; 13 Suppl 3():3-10. PubMed ID: 10491723
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Review article: rabeprazole-based therapy in Helicobacter pylori eradication.
    Barth J, Hahne W.
    Aliment Pharmacol Ther; 2002 Mar; 16 Suppl 1():31-3. PubMed ID: 11849125
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo.
    Williams MP, Usselmann B, Chilton A, Sercombe J, Nwokolo CU, Pounder RE.
    Aliment Pharmacol Ther; 2003 Mar 15; 17(6):775-83. PubMed ID: 12641499
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rabeprazole.
    Prakash A, Faulds D.
    Drugs; 1998 Feb 15; 55(2):261-7; discussion 268. PubMed ID: 9506245
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
    Horn J.
    Aliment Pharmacol Ther; 2004 Nov 15; 20 Suppl 6():11-9. PubMed ID: 15496214
    [Abstract] [Full Text] [Related]

  • 10. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Nov 15; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 11. [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].
    de Korwin JD, Ducrotté P, Vallot T.
    Presse Med; 2004 Jun 19; 33(11):746-54. PubMed ID: 15257232
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori.
    Kawakami Y, Akahane T, Yamaguchi M, Oana K, Takahashi Y, Okimura Y, Okabe T, Gotoh A, Katsuyama T.
    Antimicrob Agents Chemother; 2000 Feb 19; 44(2):458-61. PubMed ID: 10639386
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor.
    Tsuchiya M, Imamura L, Park JB, Kobashi K.
    Biol Pharm Bull; 1995 Aug 19; 18(8):1053-6. PubMed ID: 8535394
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CYP2C19 genotype and the PPIs--focus on rabeprazole.
    Lim PW, Goh KL, Wong BC.
    J Gastroenterol Hepatol; 2005 Dec 19; 20 Suppl():S22-8. PubMed ID: 16359346
    [Abstract] [Full Text] [Related]

  • 20. Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.
    Ohning GV, Barbuti RC, Kovacs TO, Sytnik B, Humphries TJ, Walsh JH.
    Aliment Pharmacol Ther; 2000 Jun 19; 14(6):701-8. PubMed ID: 10848652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.